IQVIA 23. Apr. 2026 The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags, boosting Novo's shares - Fierce Pharma
IQVIA 13. März 2026 Expanding Options for Emerging Biopharma in the U.S.: A conversation with Meg Hooton, IQVIA Biotech - IQVIA